
About CardioKinetix
CardioKinetix was a Healthcare company based in Menlo Park (United States) founded in 2003. It develops implants for treating heart failure. It operates on a B2B model. CardioKinetix has raised $137.06 million across 4 funding rounds from investors including J P Morgan, Lexington Partners and Edwards Lifesciences. The company has 23 employees. The company is recorded as dissolved. Its focus areas include Medical Devices, Cardiology and Heart Implants. Its legal entity is CARDIOKINETIX INC. Its competitors include CVRx, HeartWare and Element Science; 3 of its 3 listed competitors have raised funding.
Company details
CardioKinetix, established in 2003, excels in providing healthcare solutions, developing medical devices, cardiology, and heart implants. Develops implants for treating heart failure. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Menlo Park, United States
- Employees 23
- SectorsHealthcare
- Website cardiokinetix.com
- Social X
- Legal Name Cardiokinetix Inc
- Total Equity Funding$137.06M (USD)
in 4 rounds
- Latest Funding Round$50M (USD), Series F
Dec 2014
- InvestorsJ P Morgan
& 8 more
- Employee Count23
Funding Insights of CardioKinetix
CardioKinetix has successfully raised a total of $137.06M across 4 strategic funding rounds. The most recent funding activity was a Series F round of $50 million completed in December 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $137.06M
- Total Rounds 4
- Last Round Series F β $50M
- First Round $14.5M
(Jul 2008)
- Investors Count 9
All 4 funding rounds of CardioKinetix with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2014 | $50M | Series F | β | Edwards Lifesciences | |
| Feb 2013 | $48M | Series E | β | β | |
| Sep 2011 | $24.56M | Series C | β | β | β |
| Jul 2008 | $14.5M | Series C | β | β |
9 investors in total: 9 institutional.
Investors in CardioKinetix
CardioKinetix has secured backing from 9 investors, including institutional and venture fund investors. Prominent investors backing the company include J P Morgan, Lexington Partners and Edwards Lifesciences.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early & later stage venture capital firm investing in the US | panoramacapital.com | Campbell, United States | ||
Stage-agnostic investments in US life sciences are managed. | 2005 | nlvpartners.com | New York, United States | |
Secondary private equity and co-investments are managed diversely. | 1994 | lexingtonpartners.com | New York, United States | |
VC firm that focuses on early stage investments in the US | usvp.com | Menlo Park, United States | ||
Venture capital fund focused on early-stage healthcare startups | svhealthinvestors.com | Boston, United States | ||
US healthcare companies are invested in stage-agnostically by Cutlass Capital. | cutlasscapital.com | Boston, United States | ||
Medical devices for structural heart disease are developed and provided. | 1958 | edwards.com | Irvine, United States | |
Investment advisory services are provided to financial clients. | 1986 | teklacap.com | Boston, United States | |
Comprehensive financial services are provided to corporations and individuals. | 1799 | jpmorgan.com | New York, United States |
Investor details for CardioKinetix
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of CardioKinetix
1 people are tracked at CardioKinetix (1 in leadership); the tracked headcount is 23.
| Name | Role | Group |
|---|---|---|
Maria Sainz | President and CEO | Leadership |
Complete people profiles for CardioKinetix
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of CardioKinetix
3 dated milestones of CardioKinetix across 11 years, from founding to its latest funding, stage changes and deals.
- Founded CardioKinetix is founded.
- Funding First funding round of $14.5M.
- Funding Latest funding round, Series F, of $50.0M.
Competitors of CardioKinetix
CardioKinetix has 3 listed competitors in our database, 3 of them funded. They include CVRx, HeartWare and Element Science.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| cvrx.com | 2001 | Minneapolis, United States | $368.5M | 142 | Implantable technology for hypertension and heart failure is developed. | |
| heartware.com | 2005 | Framingham, United States | $12.38M | 547 | Miniaturized ventricular assist devices are developed for heart failure treatment. | |
| elementscience.com | 2013 | San Francisco, United States | $192.6M | Wearable patch defibrillators are developed for sudden cardiac arrest treatment. |
Detailed competitors of CardioKinetix
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of CardioKinetix
Websites that share an audience with CardioKinetix (cardiokinetix.com).
Websites whose visitors overlap most with CardioKinetix. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| atricure.com | 83% | 18.2K | #1,529,838 | View details |
Top companies in Cardiac and Vascular Disorders
3 companies that operate in the same segment as CardioKinetix (Cardiac and Vascular Disorders) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | 255 | ||
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cardiokinetix
Complete news archive for CardioKinetix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CardioKinetix
CardioKinetix was founded in 2003 and raised its 1st funding round 5 years after it was founded.
CardioKinetix is headquartered in Menlo Park, United States. It is registered at Menlo Park, California, United States.
CardioKinetix is a funded company, having raised a total of $137.06M across 4 funding rounds to date. The company's 1st funding round was a Series C of $14.5M, raised on Jul 2008.
CardioKinetix has 23 employees.
CardioKinetix, established in 2003, excels in providing healthcare solutions, developing medical devices, cardiology, and heart implants. Develops implants for treating heart failure. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide. It continues to evolve, meeting industry challenges with strategic approaches.
CardioKinetix's top competitors include CVRx, Element Science and HeartWare.
CardioKinetix has 9 investors. Key investors include J P Morgan, Lexington Partners, Edwards Lifesciences, New Leaf Venture Partners, and Tekla Capital Management.
CardioKinetix operates through Cardiokinetix Inc.
